openPR Logo
Press release

Global Inhalation CDMO Market to Reach USD 16.68 Billion by 2035, Driven by Rising Respiratory Disease Burden and Advanced Drug Delivery Technologies

04-03-2026 01:08 PM CET | Health & Medicine

Press release from: Future Market Insights

Global Inhalation CDMO Market to Reach USD 16.68 Billion by 2035,

NEWARK, DE / April 3, 2026 - The global inhalation contract development and manufacturing organization (CDMO) market is poised for significant growth, projected to expand from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, registering a CAGR of 5.7% during the forecast period. This growth is being fueled by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and rising demand for outsourced pharmaceutical manufacturing services.

The market is undergoing rapid transformation, supported by innovations in inhalation devices such as dry powder inhalers (DPIs), metered-dose inhalers (MDIs), and nebulizers. Additionally, the integration of digital technologies-including smart inhalers with sensors and connectivity-is enhancing patient monitoring, adherence, and therapeutic outcomes.

Read Full Report:https://www.futuremarketinsights.com/reports/inhalation-cdmo-market

Direct Answers (AEO)

Market Size (2025): USD 9.13 billion
Forecast Value (2035): USD 16.68 billion
CAGR (2025-2035): 5.7%
Leading Segment: Commercial-scale manufacturing (70.2% share)
Key Growth Driver: Rising respiratory disease prevalence and demand for advanced inhalation therapies

Key Market Drivers

The inhalation CDMO market is expanding due to several critical factors:

Growing global burden of respiratory diseases such as asthma and COPD
Increasing adoption of inhalation therapies for targeted drug delivery
Rising demand for outsourcing manufacturing to specialized CDMOs
Advancements in biologics, biosimilars, and inhalation technologies
Integration of digital health features in inhaler devices

Emerging Trends Shaping the Market

Smart Inhalers: Integration of sensors for real-time usage tracking
Personalized Medicine: Tailored inhalation therapies for specific patient groups
Digital Healthcare Ecosystems: Enhanced patient-provider connectivity
Biologic Inhalation Therapies: Increasing development of complex formulations
Regulatory Support: Favorable policies encouraging innovation

Market Segmentation Insights

By Scale of Operation

Commercial Segment: Dominates with 70.2% market share (2025)
Driven by demand for large-scale production of inhalation drugs

By Service

Formulation Development: Holds 42.5% share
Increasing need for specialized and high-performance inhalation formulations

By Product

Dry Powder Inhalers (DPIs)
Metered Dose Inhalers (MDIs)
Soft Mist Inhalers
Nebulized solutions

Regional Growth Insights

United States: Largest market with 33.1% share (2024), driven by high disease prevalence
China: Fastest-growing due to rising pollution and smoking rates
Germany: Strong pharmaceutical infrastructure supporting CDMO demand
Japan: Favorable regulations and advanced R&D ecosystem
Spain: Growth supported by aging population and healthcare demand

Competitive Landscape

The inhalation CDMO market is highly competitive, with leading players focusing on innovation, partnerships, and capacity expansion. Key companies include:

Lonza Group
Catalent
Recipharm
WuXi AppTec
AptarGroup, Inc.
Hovione
Gerresheimer AG
Stevanato Group

Strategic collaborations and acquisitions remain central to strengthening capabilities and expanding service offerings.

Notable Industry Development

On July 24, 2024, Catalent expanded its collaboration with De Motu Cordis (DMC) to support the development of DMC-IH1, an inhaled dry powder epinephrine for emergency anaphylaxis treatment. This partnership includes large-scale manufacturing and highlights the growing importance of end-to-end CDMO capabilities.

Market Drivers and Challenges

Growth Drivers

Increasing respiratory disease prevalence
Rising demand for advanced inhalation therapies
Expansion of biologics and personalized medicine
Growth in pharmaceutical outsourcing

Key Challenges

High cost of advanced inhalation technologies
Stringent regulatory requirements
Complex manufacturing processes
Economic uncertainties affecting healthcare spending

Strategic Takeaways for Decision Makers

Invest in advanced inhalation technologies and biologics
Expand capabilities in formulation development and commercial manufacturing
Strengthen regulatory compliance and global market access
Leverage digital health integration in inhalation devices
Build strategic partnerships across the pharmaceutical value chain

Subscribe for Year-Round Insights → Stay ahead with quarterly and annual updates: https://www.futuremarketinsights.com/reports/brochure/rep-gb-18772

Request Sample Report | Customize Report | Purchase Full Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-18772

Why This Market Matters Now

The inhalation CDMO market is becoming a critical pillar in modern pharmaceutical manufacturing as healthcare systems increasingly prioritize efficient, targeted, and patient-friendly drug delivery methods. With respiratory diseases on the rise and innovation accelerating in inhalation technologies, CDMOs are playing a vital role in enabling scalable, cost-effective, and high-quality production of next-generation therapies.

As digital transformation and personalized medicine continue to reshape the healthcare landscape, the inhalation CDMO market presents strong opportunities for sustainable growth, innovation, and improved patient outcomes.

Explore More Related Studies Published by FMI Research:

Clinical Trials Market- https://www.futuremarketinsights.com/reports/clinical-trials-market

Lung Cancer Surgery Market- https://www.futuremarketinsights.com/reports/lung-cancer-surgery-market

Veterinary Vaccines Market- https://www.futuremarketinsights.com/reports/veterinary-vaccines-market

Weight Loss and Obesity Management Market- https://www.futuremarketinsights.com/reports/weight-loss-and-obesity-management-market

Lung Cancer Therapeutics Market- https://www.futuremarketinsights.com/reports/lung-cancer-therapeutics-market

Why FMI: Decisions that Change Outcomes- https://www.futuremarketinsights.com/why-fmi

Have a specific Requirements and Need Assistant on Report Pricing or Limited Budget please contact us - sales@futuremarketinsights.com

Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

About Future Market Insights (FMI)

Future Market Insights, Inc. (FMI) is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization, trusted by Fortune 500 clients and global enterprises. With operations in the U.S., UK, India, and Dubai, FMI provides data-backed insights and strategic intelligence across 30+ industries and 1200 markets worldwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Inhalation CDMO Market to Reach USD 16.68 Billion by 2035, Driven by Rising Respiratory Disease Burden and Advanced Drug Delivery Technologies here

News-ID: 4454111 • Views:

More Releases from Future Market Insights

Global Automated External Defibrillator Market to Reach USD 4.8 Billion by 2036, Driven by Public Access Deployment and Smart Emergency Response Systems
Global Automated External Defibrillator Market to Reach USD 4.8 Billion by 2036, …
NEWARK, DE / April 3, 2026 - The global automated external defibrillator (AED) market is projected to grow steadily from USD 3.1 billion in 2026 to USD 4.8 billion by 2036, registering a CAGR of 4.5% during the forecast period, according to Future Market Insights (FMI). This growth reflects a structural shift in emergency cardiac care, where response to sudden cardiac arrest is moving from hospital-dependent treatment toward community-based intervention
Global Plant-Based API Market to Reach USD 7.8 Billion by 2036, Driven by Regulatory Support and Shift Toward Natural Drug Development
Global Plant-Based API Market to Reach USD 7.8 Billion by 2036, Driven by Regula …
NEWARK, DE / April 3, 2026 - The global plant-based active pharmaceutical ingredient (API) market is set for robust expansion, projected to grow from USD 4.2 billion in 2026 to USD 7.8 billion by 2036, registering a CAGR of 6.4% during the forecast period, according to Future Market Insights (FMI). This growth reflects a structural transformation in pharmaceutical manufacturing, as drug development increasingly shifts from synthetic compounds toward botanical extraction
Global Organ Preservation & Perfusion Products Market to Reach USD 590.95 Million by 2036, Driven by Shift Toward Machine Perfusion Technologies
Global Organ Preservation & Perfusion Products Market to Reach USD 590.95 Millio …
NEWARK, DE / 2/April/2026 - The global organ preservation & perfusion products market is poised for steady growth, expanding from USD 314.81 million in 2026 to USD 590.95 million by 2036, registering a CAGR of 6.5% during the forecast period, according to Future Market Insights (FMI). The market is witnessing a pivotal transition from traditional static cold storage to advanced machine perfusion systems, enabling enhanced organ viability, extended preservation times,
Global Oral Controlled Release Drug Delivery Technology Market to Reach USD 90.45 Billion by 2036, Driven by Rising Chronic Disease Burden and Advanced Formulation Technologies
Global Oral Controlled Release Drug Delivery Technology Market to Reach USD 90.4 …
NEWARK, DE/ April 3, 2026 - The global oral controlled release drug delivery technology market is poised for substantial growth, projected to expand from USD 45.13 billion in 2026 to USD 90.45 billion by 2036, registering a CAGR of 7.20% during the forecast period, according to Future Market Insights (FMI). The market is witnessing accelerated demand due to the increasing prevalence of chronic diseases, growing need for patient-friendly dosage regimens,

All 5 Releases


More Releases for CDMO

FDP CDMO Research: China FDP CDMO market size is projected to reach USD 1.33 bil …
QY Research Inc. (Global Market Report Research Publisher) announces the release of 2025 latest report "Fraud Detection and Prevention (FDP) System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031". Based on current situation and impact historical analysis (2020-2024) and forecast calculations (2025-2031), this report provides a comprehensive analysis of the global Wire Drawing Dies market, including market size, share, demand, industry development status, and forecasts for the
Global Cmo And Cdmo Biotechnology Market Size by Application, Type, and Geograph …
According to Market Research Intellect, the global Cmo And Cdmo Biotechnology market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period. Biologics and sophisticated medicines are driving the biotechnology industry for Contract Manufacturing Organizations (CMO) and Contract
Evolving Market Trends In The Inhalation CDMO Industry: Strategic Collaborations …
The Inhalation CDMO Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Inhalation CDMO Market Size During the Forecast Period? In recent times, the inhalation CDMO market has experienced significant growth. The market value is expected to increase from $2.08 billion in 2024
What's Driving the Inhalation CDMO Market 2025-2034: Rising Respiratory Disorder …
How Is the Chondroplasty Market Projected to Grow, and What Is Its Market Size? The chondroplasty market has seen strong growth in recent years. It will increase from $13.77 billion in 2024 to $14.68 billion in 2025 at a CAGR of 6.5%. This growth is attributed to the rise in sports-related injuries, patient preference for non-total joint replacement procedures, advances in postoperative care, healthcare provider training, and an increasing incidence of
Lentiviral Vector (LVV) CDMO Services Market Delivering Cures: The Role of LVV C …
Lentiviral Vector (LVV) CDMO Services Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Lentiviral Vector (LVV) CDMO Services Market - (By Type (IIT Grade, IND Grade, Clinical Trial Grade, Commercial Production Grade), By Application (Biopharmaceutical Company, Academic Scientific Research Institution)), Trends, Industry Competition Analysis, Revenue and Forecast To
Electronic Chemicals CDMO Market Fueling the Electronics Boom: The Rise of the E …
Electronic Chemicals CDMO Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Electronic Chemicals CDMO Market - (By Type (Metals and Pastes, Electronic Specialty Gases, Polymer Compounds, Others), By Application (Battery, Semiconductor, Integrated Circuit, Consumer Electronics, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest